Showing 1–11 of 11 results
-
Amendments and Corrections |
-
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials
- C Piette
- , S Suciu
- , E Clappier
- , Y Bertrand
- , S Drunat
- , S Girard
- , K Yakouben
- , G Plat
- , N Dastugue
- , F Mazingue
- , N Grardel
- , N van Roy
- , A Uyttebroeck
- , V Costa
- , O Minckes
- , N Sirvent
- , P Simon
- , P Lutz
- , A Ferster
- , C Pluchart
- , M Poirée
- , C Freycon
- , M-F Dresse
- , F Millot
- , C Chantrain
- , J van der Werff ten Bosch
- , K Norga
- , C Gilotay
- , P-S Rohrlich
- , Y Benoit
- & H Cavé
-
-
Research |
-
-
Research |
-
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report
- E Vilmer
- , S Suciu
- , A Ferster
- , Y Bertrand
- , H Cavé
- , A Thyss
- , Y Benoit
- , N Dastugue
- , M Fournier
- , G Souillet
- , A-M Manel
- , A Robert
- , B Nelken
- , F Millot
- , P Lutz
- , X Rialland
- , F Mechinaud
- , P Boutard
- , C Behar
- , J-M Chantraine
- , E Plouvier
- , G Laureys
- , P Brock
- , A Uyttebroeck
- , G Margueritte
- , D Plantaz
- , L Norton
- , N Francotte
- , J Gyselinck
- , C Waterkeyn
- , G Solbu
- , N Philippe
- & J Otten
-
Research |
-
-
Research |
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951
- E Clappier
- , N Grardel
- , M Bakkus
- , J Rapion
- , B De Moerloose
- , P Kastner
- , A Caye
- , J Vivent
- , V Costa
- , A Ferster
- , P Lutz
- , F Mazingue
- , F Millot
- , D Plantaz
- , G Plat
- , E Plouvier
- , M Poirée
- , N Sirvent
- , A Uyttebroeck
- , K Yakouben
- , S Girard
- , N Dastugue
- , S Suciu
- , Y Benoit
- , Y Bertrand
- & H Cavé
Leukemia 29 , 2154–2161 -
Research |
